Related references
Note: Only part of the references are listed.Mechanisms of muscle atrophy and hypertrophy: implications in health and disease
Roberta Sartori et al.
NATURE COMMUNICATIONS (2021)
Breakdown of Filamentous Myofibrils by the UPS-Step by Step
Dina Aweida et al.
BIOMOLECULES (2021)
Cyclic nucleotide phosphodiesterases: New targets in the metabolic syndrome?
Claire Lugnier et al.
PHARMACOLOGY & THERAPEUTICS (2020)
cAMP-dependent protein kinase inhibits FoxO activity and regulates skeletal muscle plasticity in mice
Wilian A. Silveira et al.
FASEB JOURNAL (2020)
Signaling Pathways That Control Muscle Mass
Anna Vainshtein et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Skeletal Muscle Recovery from Disuse Atrophy: Protein Turnover Signaling and Strategies for Accelerating Muscle Regrowth
Timur M. Mirzoev
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
Jakub Mesinovic et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Regulation of cAMP accumulation and activity by distinct phosphodiesterase subtypes in INS-1 cells and human pancreatic β-cells
Evan P. S. Pratt et al.
PLOS ONE (2019)
FoxO Transcription Factors Are Critical Regulators of Diabetes-Related Muscle Atrophy
Brian T. O'Neill et al.
DIABETES (2019)
Phosphodiesterase 4B knockout prevents skeletal muscle atrophy in rats with burn injury
Ambikaipakan Balasubramaniam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2018)
Release of skeletal muscle peptide fragments identifies individual proteins degraded during insulin deprivation in type 1 diabetic humans and mice
Matthew M. Robinson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Cytokine Signaling in Skeletal Muscle Wasting
Jin Zhou et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Differential control of muscle mass in type 1 and type 2 diabetes mellitus
David Sala et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy
Giulia Milan et al.
NATURE COMMUNICATIONS (2015)
Skeletal Muscle: A Brief Review of Structure and Function
Walter R. Frontera et al.
CALCIFIED TISSUE INTERNATIONAL (2015)
Supplementation of ketoacids contributes to the up-regulation of the Wnt7a/Akt/p70S6K pathway and the down-regulation of apoptotic and ubiquitin-proteasome systems in the muscle of 5/6 nephrectomised rats
Dong-Tao Wang et al.
BRITISH JOURNAL OF NUTRITION (2014)
Activating cAMP/PKA signaling in skeletal muscle suppresses the ubiquitin-proteasome-dependent proteolysis: implications for sympathetic regulation
W. A. Silveira et al.
JOURNAL OF APPLIED PHYSIOLOGY (2014)
Phosphodiesterase (PDE) inhibitor torbafylline (HWA 448) attenuates burn-induced rat skeletal muscle proteolysis through the PDE4/cAMP/EPAC/PI3K/Akt pathway
Rashika Joshi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases
Rita Rastogi Kalyani et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1
Riku Korhonen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Cellular and molecular mechanisms of muscle atrophy
Paolo Bonaldo et al.
DISEASE MODELS & MECHANISMS (2013)
SIRT1 Protein, by Blocking the Activities of Transcription Factors FoxO1 and FoxO3, Inhibits Muscle Atrophy and Promotes Muscle Growth
Donghoon Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt
Dawit A. P. Goncalves et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments
Therese Keravis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
PHOSPHODIESTERASE-4 INHIBITION REDUCES PROTEOLYSIS AND ATROGENES EXPRESSION IN RAT SKELETAL MUSCLES
Eduardo C. Lira et al.
MUSCLE & NERVE (2011)
Involvement of cAMP/Epac/PI3K-dependent pathway in the antiproteolytic effect of epinephrine on rat skeletal muscle
Amanda Martins Baviera et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Pretreatment with insulin-like growth factor I protects skeletal muscle cells against oxidative damage via PI3K/Akt and ERK1/2 MAPK pathways
Shi Yu Yang et al.
LABORATORY INVESTIGATION (2010)
Mechanisms Involved in 3′,5′-Cyclic Adenosine Monophosphate-Mediated Inhibition of the Ubiquitin-Proteasome System in Skeletal Muscle
Dawit A. P. Goncalves et al.
ENDOCRINOLOGY (2009)
Pentoxifylline inhibits Ca2+-dependent and ATP proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats
Amanda Martins Baviera et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Phosphodiesterase inhibitors
V Boswell-Smith et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy
RT Hinkle et al.
MUSCLE & NERVE (2005)
Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway
I Kramerova et al.
HUMAN MOLECULAR GENETICS (2005)
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
M Sandri et al.
CELL (2004)
Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle
TJ Bloom
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2002)
Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle
LCC Navegantes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2000)
Share Paper
